Michal Tsur

Michal Tsur (; born 1973) is an Israeli serial entrepreneur who lived in New York. She is the co-founder and co-CEO of Remepy, and was co-founder and president of Kaltura, Nasdaq: KLTR, and co-founder and vice-president of Cyota, acquired by RSA Security Nasdaq: RSAS.

Biography

Early life and education Tsur was born in Jerusalem. She completed a doctoral degree in Law, focusing on game theoretic economic analysis of law from New York University. She was then a post-doctoral fellow at Yale Law School's Information Society Project. She was driven by research, working at Hebrew University in Jerusalem Kaltura was listed on Nasdaq:KLTR in 2021.

in 2022, Tsur together with 2 friends, co-founded Remepy, to bring to market Hybrid Drugs, that combine tranditional drugs with therapeutic software.

Later on that year Tsur was quoted that the best Parkinson'd Disease medication will be developed in Israel and it will be hybrid.

Tsur has authored and contributed to many articles regarding women in tech.